Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
118 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00021255 | Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer | completed | Phase 3 | 3,222 | SanofiINDUSTRY | 42 | Nov 15, 2016 | clinicaltrials |
| NCT02273856 | Multicentre Registry of Treatments and Outcomes in Patients With Chronic Lymphocytic Leukaemia (CLL) Or Indolent Non Hodgkin's Lymphoma (iNHL)(NADIR) | terminated | — | 25 | Astellas Pharma International B.V.INDUSTRY | 7 | Jun 21, 2016 |
| clinicaltrials |
| NCT00451906 | A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. | completed | Phase 4 | 2,252 | Hoffmann-La RocheINDUSTRY | 40 | May 24, 2016 | clinicaltrials |
| NCT01254188 | Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients(ENESTxtnd) | completed | Phase 3 | 421 | Novartis PharmaceuticalsINDUSTRY | 19 | Mar 3, 2016 | clinicaltrials |
| NCT01234311 | A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer | completed | Phase 3 | 1,245 | Active Biotech ABINDUSTRY | 37 | Oct 21, 2015 | clinicaltrials |
| NCT02125487 | Hybrid Simulation in Teaching Clinical Breast Examination(HS-CBE) | completed | N/A | 82 | American University of Beirut Medical CenterOTHER | 1 | Jun 24, 2015 | clinicaltrials |
| NCT00448591 | A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer. | completed | Phase 3 | 2,296 | Hoffmann-La RocheINDUSTRY | 36 | May 25, 2015 | clinicaltrials |
| NCT00242567 | Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer | completed | Phase 3 | 522 | Novartis PharmaceuticalsINDUSTRY | 10 | May 7, 2014 | clinicaltrials |
| NCT01081626 | Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction | completed | Phase 4 | 310 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 3 | Feb 13, 2014 | clinicaltrials |
| NCT00312208 | Docetaxel in Breast Cancer | completed | Phase 3 | 3,299 | SanofiINDUSTRY | 37 | Dec 30, 2013 | clinicaltrials |
| NCT01541683 | The Effect of Mentholyptus Drops on the Palatability of PEG-Electrolyte Solution | completed | N/A | 99 | American University of Beirut Medical CenterOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00945360 | Aromatase Inhibitors for Treatment of Uterine Leiomyomas | withdrawn | Phase 1 | 0 | American University of Beirut Medical CenterOTHER | 1 | Jul 13, 2012 | clinicaltrials |
| NCT00130897 | Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma | approved for marketing | — | — | PfizerINDUSTRY | 50 | Mar 9, 2012 | clinicaltrials |
| NCT00606021 | A Study Comparing of Two Different Chemotherapy Regimens, in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer | completed | Phase 2 | 106 | Eli Lilly and CompanyINDUSTRY | 3 | Dec 26, 2011 | clinicaltrials |
| NCT00302016 | Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 34 | Aug 26, 2011 | clinicaltrials |
| NCT00655252 | Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 13 | Aug 19, 2011 | clinicaltrials |
| NCT00294385 | Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine | completed | Phase 3 | 430 | Central European Cooperative Oncology GroupOTHER | 7 | Jun 23, 2011 | clinicaltrials |
| NCT00403988 | Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast Carcinoma | terminated | Phase 2 | 40 | American University of Beirut Medical CenterOTHER | 1 | Nov 4, 2008 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials